Snapshot Highlights
- Pioneering Bone Marrow Transplant specialist in Hematology.
- Associate Professor at Marmara University Faculty of Medicine.
- Authored significant research in thalassaemia and leukemia.
- Extensive international experience including University College Hospital, London.
Dr. SIRET RATIP
Professional Experience
Dr. Siret Ratip brings over two decades of dedicated experience to the field of Hematology, with a specialized focus on Bone Marrow Transplant for adult patients. His career trajectory demonstrates a profound commitment to advancing patient care and research within this complex medical discipline. Since 2002, Dr. Ratip has been a key figure at Acıbadem Health Group, contributing his expertise to their esteemed medical team. Prior to this, he served at Marmara University Faculty of Medicine from 1996 to 2002, holding positions that underscored his growing authority in Hematology. His clinical and academic journey includes significant periods at Marmara University Medical Faculty Hospital, further solidifying his practical experience.
Education and Advanced Training
Dr. Siret Ratip’s foundational medical education was completed at Marmara University Faculty of Medicine, where he earned his credentials and progressed to achieve the esteemed position of Associate Professor. His specialization in Hematology was cultivated at Marmara University Faculty of Medicine, building upon a strong background in Internal Medicine from the same institution. Furthering his commitment to global medical standards and research, Dr. Ratip undertook significant postgraduate work in London. He completed a PhD in Haematology at University College Hospital, London, a testament to his advanced research capabilities. His academic pursuits also include a Masters in Clinical Genetics from the Institute of Child Health, London, highlighting a comprehensive understanding of genetic influences in blood disorders.
Professional Affiliations and Contributions
As a respected member of the medical community, Dr. Ratip actively participates in leading professional organizations, including the British Society of Haematology and the Turkish Hematology Association. These memberships reflect his commitment to staying at the forefront of hematological advancements and fostering collaborative research. Dr. Ratip’s scholarly contributions are extensive, with numerous publications in peer-reviewed journals. His research spans critical areas such as the psychosocial aspects of thalassaemia, the genetic factors influencing blood disorders, and the efficacy of various treatment modalities for conditions like idiopathic thrombocytopenic purpura and acute leukemia. His work on bone marrow transplantation outcomes, including the frequency of tuberculosis in transplant recipients, further establishes his authority in the field.
Select Publications
- Dr. Ratip’s research on the psychosocial and clinical aspects of thalassaemia intermedia and its implications for prenatal diagnosis was published in the Archives of Disease in Childhood.
- He co-authored a seminal review on the psychosocial and sociological aspects of the thalassaemias in Seminars in Haematology.
- Investigating the relationship between beta thalassaemia severity and alleviating mutations, his work appeared in the European Journal of Haematology.
- He contributed to research on the psychosocial burden of Cooley’s anemia in the Annals of New York Academy of Sciences.
- Dr. Ratip’s studies include the frequency of tuberculosis in adult allogeneic stem cell transplant recipients in Turkey, published in Biology of Blood and Marrow Transplantation.
- His work on DNA histograms and their association with clinical outcomes in acute leukemia was featured in Leukemia and Lymphoma.
- He explored the role of hepatocyte growth factor in dendritic cell development from CD34+ bone marrow cells in Haematologica.
- A case study on Scleredema of Buschke associated with Waldenström’s macroglobulinaemia was published in the British Journal of Dermatology.
- Dr. Ratip was also involved in research on the efficacy of high-dose methylprednisolone for adult idiopathic thrombocytopenic purpura, published in the British Journal of Haematology.